期刊文献+

2013-2014年泉州地区肺炎链球菌感染的分布及耐药性分析 被引量:12

Infection distribution and drug resistance analysis of Streptococcus pneumonia isolated from Quanzhou in 2013-2014
下载PDF
导出
摘要 目的了解泉州地区2013-2014年临床分离的肺炎链球菌(Streptococcus pneumoniae,SP)的感染情况及耐药性特点,为临床合理使用抗菌药物提供依据。方法回顾性分析福建医科大学附属泉州市第一医院和福建医科大学附属二院2013-2014年医院分离到的661株SP的临床资料,并对细菌的耐药性进行统计分析。结果 SP分离株主要标本来源为痰液和血液,占86.82%和4.67%;SP分离株主要来源于儿科等相关专业科室;感染的人群主要为5岁以下儿童及50岁以上的老年人。SP对红霉素、克林霉素、四环素、复方新诺明、青霉素、头孢噻肟、头孢吡肟、美洛培南、阿莫西林、氯霉素、左旋氧氟沙星的耐药率分别99.2%、95.6%、85.3%、75.0%、25.7%、41.2%、35.8%、22.8%、21.5%、12.4%、4.4%,对替考拉宁、利奈唑胺、万古霉素的敏感率均为100%。耐药谱分析发现SP主要表现出对红霉素-克林霉素-四环素-复方新诺明耐药,占41.61%,而且耐5种及5种以上抗生素的菌株各占19.94%和18.31%;青霉素耐药的菌株同时表现出对红霉素、克林霉素、四环素、复方新诺明的耐药,青霉素耐药与敏感菌株在复方新诺明、头孢噻肟、头孢吡肟、美洛培南组间耐药率比较差异均具有统计学意义(P<0.05)。结论临床感染SP主要人群以5岁以下的儿童及50岁以上的老年人,临床分离的菌株更多的表现为多重耐药,应进一步规范临床抗菌药物的使用。 Objective To analyze the clinical infection feature and drug resistance of Streptococcus pneumonia(SP) isolated from Quanzhou region in 2013-2014, and to provide evidence for clinical use of antibiotics.Methods The clinical data of 661 SP strains from Quanzhou First Hospital Affiliated to Fujian Medical University and the Second Affiliated Hospital of Fujian Medical University from 2013 to 2014 were retrospectively analyzed.And the bacterial drug resistance was analyzed by statistical method. Results SP strains were mostly isolated from specimens of sputum and blood, and the constituent ratios were 86.82% and 4.67%, respectively. The SP isolates mainly distributed in Department of Pediatrics and the related departments. Infected people were mainly children under 5years old and the elderly over the age of 50. The resistance rates of SP to erythromycin, clindamycin, tetracycline, cotrimoxazole, penicillin, cefotaxime, cefepime, meropenem, amoxicillin, chloramphenicol, ofloxacin were 99.2%,95.6%, 85.3%, 75.0%, 25.7%, 41.2%, 35.8%, 22.8%, 21.5%, 12.4%, 4.4%, respectively, and the susceptibility rates to teicoplanin, linezolid, vancomycin were all 100%. SP strains were mostly resistant to erythromycin, clindamycin, tetracycline, cotrimoxazole simultaneously, with the positive rate of 41.61%. The constituent ratios of SP strains resistant to five and more drugs were 19.94% and 18.31%, respectively. The SP strains resistant to penicillin also showed resistance to erythromycin, clindamycin, tetracycline, cotrimoxazole. There was statistically significant differences between the penicillin-resistant strains and penicillin-sensitive strains in the resistance to cotrimoxazole, cefotaxime, cefepime, meropenem(P〈0.05). Conclusion The SP strains are mainly isolated from children under 5 years old and the elderly over the age of 50, which mostly show multi-drug resistance. Appropriate antibiotics should be selected for the treatment of infection according to drug sensitivity.
出处 《海南医学》 CAS 2015年第24期3655-3658,共4页 Hainan Medical Journal
基金 福建省卫生厅青年课题(编号:2012-1-42) 泉州市科技计划项目(编号:2012Z73)
关键词 肺炎链球菌 耐药性 感染 泉州地区 Streptococcus pneumoniae Drug resistance Infection Quanzhou region
  • 相关文献

参考文献5

二级参考文献41

  • 1李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 2姚成,余泽波,肖永红.重庆地区肺炎链球菌耐药性和分子流行病学调查[J].中华流行病学杂志,2005,26(6):431-434. 被引量:7
  • 3刘丽群,赵根明.肺炎链球菌疾病的流行病学[J].中国抗感染化疗杂志,2005,5(5):314-317. 被引量:10
  • 4Liu Y,Chen M,Zhao T,et al.Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population.BMC Infect Dis,2009,18:31.
  • 5Jones RN,Jacobs MR,Sader HS.Evolving trends in Streptococcus pneumoniae resistance:implications for therapy of community-acquired bacterial pneumonia.Int J Antimicrob Agents,2010,36:197-204.
  • 6Lynch JP 3rd,Zhanel GG.Streptococcus pneumoniae:does antimicrobial resistance matter? Semin Respir Crit Care Med,2009,30:210-238.
  • 7Clinical and Laboratory Standards Institute.CLSI documents M7-A8 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-seventh Edition; Approved Standard.Wayne,Pa:CLSI,2009,29.
  • 8Clinical and Laboratory Standards Institute.CLSI documents M2-A10 Performance standards for antimicrobial Disk susceptibility tests; Approved Standard-tenth edition.Wayne,Pa:CLSI,2009,29.
  • 9Clinical and Laboratory Standards Institute.CLSI documents M100-S20 Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement.Wayne,Pa:CLSI,2010,30.
  • 10Do(g)an O,Gülmez D,Has(c)elik G.Effect of New Breakpoints Proposed by Clinical and Laboratory Standards Institute in 2008 for Evaluating Penicillin Resistance of Streptococcus pneumoniae in a Turkish University Hospital.Microb Drug Resist,2010,16:39-41.

共引文献187

同被引文献105

引证文献12

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部